Coya Therapeutics, Inc. (COYA) Stock Statistics & Valuation Metrics

Coya Therapeutics, Inc. has a market cap or net worth of ―. The enterprise value is $66.41M.

Coya Therapeutics, Inc. has 16,725,080 shares outstanding. The number of shares has decreased by -2.65% in one year.

Coya Therapeutics, Inc.’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -40.60%.

The current PE Ratio of Coya Therapeutics, Inc. is ―. Coya Therapeutics, Inc.’s PEG ratio is -0.24.

In the last 12 months, Coya Therapeutics, Inc. had revenue of 3.55M and earned -14.88M in profits. Earnings per share was -0.98.

In the last 12 months, operating cash flow was -8.61B and capital expenditures -25.00K, giving a free cash flow of -8.61B billion.

Coya Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Coya Therapeutics, Inc. upcoming earnings date is Nov 5, 2025, After Close (Confirmed).

Coya Therapeutics, Inc. as a current ratio of 11.59, with Debt / Equity ratio of 0.00%

In the past 12 months, Coya Therapeutics, Inc. has paid -720.00K in taxes.

Coya Therapeutics, Inc. EV to EBITDA ratio is -2.84, with an EV/FCF ratio of -4.76.

Coya Therapeutics, Inc. has $29.76B in cash and marketable securities with $0.00 in debt, giving a net cash position of $29.76B billion.

Gross margin is 95.15%, with operating margin of -485.37%, and net profit margin of -418.71%.

The average price target for Coya Therapeutics, Inc. is $17.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy